Remove CBD Remove DEA Remove Hemp Remove Safety
article thumbnail

USDA NON-ENFORCEMENT OF DEA-LAB AND DISPOSAL REQUIREMENTS

Cannabis Law Report

After a significant outcry by the hemp community, the USDA is backing down from its requirement that all hemp be tested at DEA-registered labs for the 2020 season. However, hemp producers should be aware that the USDA expects to begin enforcing the requirement to use DEA-registered labs for the 2021 growing season.

DEA 59
article thumbnail

Scientists Sue DEA as it Drags its Feet and Hampers Cannabis Research

WeedAdvisor

Despite mounting evidence into cannabis’ therapeutic benefits, the DEA continues to close its eyes and plug its ears, constantly claiming that there is not enough research to support its medicinal value, according to Marijuana Moment. It could be argued that the DEA is hesitant for the sake of public safety.

DEA 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Six Things You Need to Know About CBD and Other Hemp-containing Pet Products

Cannabis Law Report

Analysts predict that pet-and-animal product sales are among the fastest-growing sectors in the CBD market with estimated sales reaching $125 million by 2022. The basics on CBD, hemp and the 2018 Farm Bill. Hemp or any derivatives remain Unapproved Ingredients for use in animal food of any kind or any species.

Pets 105
article thumbnail

Delta-8 Study Finds Products Used More In States Without Legal Cannabis

Veriheal

Since the passage of the 2018 Farm Bill , which permits the distribution of hemp-derived products at the federal level, the popularity of delta-8, delta-9, and delta-10 products has surged. Cannabidiol (CBD) use is also higher in states without legal cannabis. Since hemp products must contain less than 0.3%

article thumbnail

Video – US Hemp Roundtable: House Agriculture Leaders Urge Congress To Regulate CBD In Upcoming Farm Bill

Cannabis Law Report

An Examination of the USDA Hemp Production Program. Testimonies During The House Agriculture Subcommittee On Biotechnology, Horticulture, And Research Addressed FDA Inaction on CBD and Intoxicating Hemp Derivatives. That reluctance, in turn, has dampened industry demand for harvested hemp material.”. Washington D.C.

article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

Though it doesn’t get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.

DEA 51
article thumbnail

Is your CBD what it says it is? Study finds high-THC weed sold as hemp

SpeedWeed

Testing failures highlight the need for national regulations on hemp. As federal and state governments tackle the legalization of hemp as a distinct product from cannabis, the safety of the products produced from hemp isn’t getting the same attention as those produced from THC-based cannabis. The results were concerning.

THC 52